Literature DB >> 9534741

From human immunodeficiency virus (HIV) infection of the brain to dementia.

G Trillo-Pazos1, I P Everall.   

Abstract

Human immunodeficiency virus (HIV) can cause both primary and secondary brain diseases. Numerous neuropathological studies have shown that up to 90% of patients with acquired immune deficiency syndrome (AIDS) have lesions in the nervous system. In this review, we discuss the entry of HIV into the brain, the general features of HIV associated neuropathology, the role of different brain cells in HIV mediated neuronal damage, and the putative molecular mechanisms involved. We conclude by correlating which factors might be important in the development of HIV associated dementia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9534741      PMCID: PMC1195889          DOI: 10.1136/sti.73.5.343

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  37 in total

Review 1.  HIV-1 Tat protein as a potential AIDS vaccine.

Authors:  G Goldstein
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

2.  Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.

Authors:  E Ramazzotti; M Vignoli; M C Re; G Furlini; M La Placa
Journal:  AIDS       Date:  1996-05       Impact factor: 4.177

3.  Neuronal loss in the frontal cortex in HIV infection.

Authors:  I P Everall; P J Luthert; P L Lantos
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

4.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

Review 5.  Neuropathology of early HIV-1 infection.

Authors:  F Gray; F Scaravilli; I Everall; F Chretien; S An; D Boche; H Adle-Biassette; L Wingertsmann; M Durigon; B Hurtrel; F Chiodi; J Bell; P Lantos
Journal:  Brain Pathol       Date:  1996-01       Impact factor: 6.508

6.  HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes.

Authors:  R M Lafrenie; L M Wahl; J S Epstein; I K Hewlett; K M Yamada; S Dhawan
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

Review 7.  Cytokines in inflammatory brain lesions: helpful and harmful.

Authors:  J E Merrill; E N Benveniste
Journal:  Trends Neurosci       Date:  1996-08       Impact factor: 13.837

8.  Expression of HIV regulatory and structural mRNA in the central nervous system.

Authors:  C A Wiley; M Baldwin; C L Achim
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

Review 9.  Human immunodeficiency virus and the brain.

Authors:  J D Glass; R T Johnson
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

10.  Cortical dendritic pathology in human immunodeficiency virus encephalitis.

Authors:  E Masliah; N Ge; M Morey; R DeTeresa; R D Terry; C A Wiley
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

View more
  3 in total

Review 1.  MR diffusion tensor imaging: a window into white matter integrity of the working brain.

Authors:  Sandra Chanraud; Natalie Zahr; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychol Rev       Date:  2010-04-27       Impact factor: 7.444

2.  Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration.

Authors:  Shahid Salaria; Haleh Badkoobehi; Edward Rockenstein; Leslie Crews; Gursharan Chana; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

3.  Transverse myelitis and acute HIV infection: a case report.

Authors:  Paulo Andrade; Cristóvão Figueiredo; Cláudia Carvalho; Lurdes Santos; António Sarmento
Journal:  BMC Infect Dis       Date:  2014-03-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.